SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing significant volatility as investors weigh a double earnings beat and raised guidance against the surprise departure of its CFO and persistent market anxiety over AI's impact on its subscription model. Community sentiment is deeply divided, with some investors aggressively buying the dip as a generational value opportunity while others view the stock as a 'value trap' in a market favoring AI-driven growth.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as retail investors and the broader community debate whether recent price swings are driven by hedge fund-led algorithmic manipulation or a fundamental reset in the memory chip sector. While some traders express frustration over the stock's volatility and alleged market manipulation, many are focused on the upcoming earnings report and the broader artificial intelligence supercycle as primary long-term catalysts.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire Corp is trending as investors weigh the stock's role as a key infrastructure partner in the space sector against dilution concerns surrounding its recently active $500 million 'at-the-market' offering. Community sentiment is deeply polarized, with many traders holding for long-term growth and potential short-squeeze activity, while others are bracing for volatility around the highly anticipated SpaceX IPO.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is experiencing heightened volatility and speculative activity driven by conflicting reports surrounding a potential U.S.-Iran peace deal and widespread anticipation ahead of the historic SpaceX IPO. Community discourse reflects a deeply polarized market, with retail participants debating whether the IPO and geopolitical news represent genuine market catalysts or calculated maneuvers for liquidity and market manipulation.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is trending after reaching a new distribution deal with NBCUniversal that restores key channels to its platform, a move some investors view as a long-awaited catalyst for growth. While bulls are excited by the potential subscriber boost ahead of the FIFA World Cup and recurring positive analyst sentiment, the community remains deeply divided, with many long-term shareholders expressing continued frustration over historical performance and management.

Entrepreneurshares Series Trust - ERShares Private-Public Crossover ETF

Investors are increasingly focused on XOVR as a rare, liquid ETF providing indirect exposure to SpaceX, with the community actively debating its valuation compared to peers like DXYZ and NASA ahead of anticipated IPO developments. Discussion is dominated by the strategic merits of holding a private-public crossover fund and whether the current market price adequately captures the fund's significant private equity weightings.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending following the official confirmation of its upcoming inclusion in the Nasdaq-100 index, a catalyst that is driving significant market speculation regarding forced passive fund inflows. While the community is actively debating the stock's valuation, insider selling patterns, and intense competition from other data center operators, many investors are focused on the potential for institutional buying pressure to reshape the stock's ownership structure.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is currently trending as investors debate whether the recent semiconductor volatility represents a healthy consolidation phase for long-term AI growth or a potential peak before a broader market correction. Community members are actively split between those aggressively buying the dip in anticipation of future data center demand and those wary that capital is rotating out of chip stocks ahead of upcoming high-profile IPOs.

Virgin Galactic Holdings, Inc. is an aerospace and space travel company, which engages in the provision of consumer space experience using reusable spaceflight systems. The firm is also involved in designing, developing, and manufacturing, ground and flight testing, spaceflight operation, and post-flight maintenance of spaceflight systems. The company was founded on May 5, 2017 and is headquartered in Tustin, CA.

Virgin Galactic Holdings Inc - Ordinary Shares - Class A

Virgin Galactic Holdings Inc

Virgin Galactic ($SPCE) is experiencing extreme volatility and heavy retail volume as traders position it as a high-beta proxy for the broader aerospace sector ahead of the highly anticipated SpaceX IPO. Community sentiment is deeply divided between those betting on a massive short squeeze driven by retail hype and ticker confusion, and those who remain skeptical of the stock's fundamental turnaround prospects.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

Lam Research is experiencing strong upward momentum driven by surging demand for semiconductor manufacturing equipment, particularly from AI infrastructure and high-bandwidth memory (HBM) production. Investors are closely monitoring the company's critical role in the advanced chip-making cycle as institutions maintain bullish sentiment despite broader market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Iovance Biotherapeutics, Inc. (IOVA) a Top Penny Stock to Buy on Amtagvi Strong Adoption

Iovance Biotherapeutics, Inc. (IOVA) a Top Penny Stock to Buy on Amtagvi Strong Adoption...

IBRX Stock Outlook After Q1 Results and a New FDA Review

ImmunityBio eyes a steadier path after a 290% YTD surge as investors watch Anktiva demand, FDA review timing and execution risks.

ImmunityBio: Anktiva Explained and What Comes Next

IBRX's Anktiva drives a 668% revenues jump in 2025 as ImmunityBio expands bladder cancer approvals and pursues new catalysts.

AGEN vs. IOVA: Which Cancer Biotech Stock Has More Upside Potential?

Iovance's commercial momentum and expanding Amtagvi pipeline make it appear better positioned than Agenus despite higher valuation.

IOVA Q1 Earnings Match Estimates, Sales Miss, Stock Down 13%

Iovance matches Q1 earnings estimates, but weaker-than-expected Amtagvi and Proleukin sales sent shares down 13% despite revenue growth.

Why Is IOVA Stock Falling Today?

Equity

During the first quarter, Iovance posted a 45% increase in revenue to $71.4 million, which came in below Wall Street’s estimates of $75.6 million, according to Fiscal.ai data.

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Lags Revenue Estimates

Iovance Biotherapeutics (IOVA) delivered earnings and revenue surprises of 0.00% and -7.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Alvotech (ALVO) Reports Q1 Loss, Lags Revenue Estimates

Alvotech (ALVO) delivered earnings and revenue surprises of -28.57% and -22.19%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue Estimates

Ultragenyx (RARE) delivered earnings and revenue surprises of -18.96% and -15.66%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Iovance Biotherapeutics (NASDAQ:IOVA) Shares Up 6.3% - Still a Buy?

Iovance Biotherapeutics (NASDAQ:IOVA) Trading 6.3% Higher - Here's What Happened...

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.13	--	--	N/A
Q1 '26	-$0.15	-$0.19	-23.68%	MISSED
Q4 '25	-$0.17	-$0.18	-2.90%	MISSED
Q3 '25	-$0.26	-$0.25	2.98%	BEAT
Q2 '25	-$0.28	-$0.33	-16.70%	MISSED

IOVAIovance Biotherapeutics Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest IOVA News